Back to Search Start Over

Global trial to evaluate Kevzara (sarilumab) as COVID-19 therapy initiated

Source :
Legal Monitor Worldwide. April 1, 2020
Publication Year :
2020

Abstract

A Phase II/III trial to investigate Kevzara (sarilumab) has been initiated in Italy, Spain, Germany, France, Japan, Canada and Russia and is enrolling patients immediately. Regeneron Pharmaceuticals and Sanofi, which [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Legal Monitor Worldwide
Publication Type :
News
Accession number :
edsgcl.619086819